Financial statements Geneme Laboratories
Balance sheet of Geneme Laboratories
Company age:
Age:
5 y. 9 m. 11 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of GENEME LABORATORIES
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 4 839,97 | 774 589,27 | 594 587,68 | 421 758,89 |
| A. Fixed assets | 0,00 | 0,00 | 36 342,30 | 4 309,41 |
| B. Current assets | 4 839,97 | 774 589,27 | 558 245,38 | 417 449,48 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | - | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | - | 0,00 |
| Total liabilities | 4 839,97 | 774 589,27 | 594 587,68 | 421 758,89 |
| A. Equity | 4 839,97 | 136 625,21 | -71 429,92 | -326 113,28 |
| B. Liabilities and provisions for liabilities | 0,00 | 637 964,06 | 666 017,60 | 747 872,17 |
| I. Long-term liabilities | - | - | - | 0,00 |
| II. Short-term liabilities | - | - | - | 671 285,01 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.